Clinical Trial Update: Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating oxymorphone IR oral liquid in post-surgical pediatric patients was terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• Oxymorphone (oxymorphone)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Post-Operative Pain, Acute Pain | Phase 3 | Status: TERMINATED | Results posted: 2021-10-26